The expected benefits of improved accessibility to information about the provision and use of HIV/AIDS pharmaceuticals and commodities include—

• Creating awareness of regions where assistance is being adequately provided and areas where assistance may be needed
  
  
• Diagnosis and aversion of problems that may result from having excessive amounts of pharmaceuticals or other commodities provided to a region in the absence of a working infrastructure that allows for the appropriate management and use of the products supplied
  
  
• Avoiding duplication of efforts by donor organizations due to the lack of a fundamental tracking system
  
  
• Creation of a centralized base for information sharing to improve management practices related to pharmaceuticals and other health commodities, as well as patient care
  
  
• Improved estimates of the number of potential patients covered by projected purchases of HIV/AIDS-related pharmaceuticals and other commodities
  
  
• Enhanced ability to determine whether proposed procurements are in line with national standard treatment guidelines

« Back to HIV/AIDS Commodities Tracking Tool Intro page